BRUSSELS, Dec 17 (Reuters) – Uber has taken its battle for
acceptance in Europe to Brussels with a complaint against a
French law, the first of what could become a series of
challenges to EU member states reluctant to open their markets
to the online taxi-booking service.
Launched in California four years ago, the service has
rapidly become popular in a number of countries because it often
undercuts established taxi and minicab services.
BRUSSELS (Reuters) – The Palestinian Islamist group Hamas should be removed from the European Union’s terrorist list, an EU court ruled on Wednesday, saying the decision to include it was based on media reports not considered analysis.
However, in its ruling, the bloc’s second highest tribunal, the General Court of the European Union, said EU member states could maintain their freeze on Hamas’s assets for three months to give time for further review or to appeal the verdict.
BRUSSELS (Reuters) – The U.S. Federal Reserve would give the clearest signal next week that its easy money stance is ending if, as some expect, it drops its two-year long pledge to keep interest rates close to zero for a “considerable time”.
The Fed, which meets on Tuesday and Wednesday, first inserted that wording in its post-meeting statements in December 2012, promising then to maintain its highly accommodative monetary stance for a considerable time after its asset purchase program ends and the economic recovery strengthens.
BRUSSELS (Reuters) – Belgium’s Queen Fabiola, widow of King Baudouin and queen between 1960 and 1993, died on Friday at the age of 86, the royal palace said.
The Spanish-born queen, who was at the center of a row last year over royal allowances, had been ill for some time and her breathing never fully recovered from a lung infection in 2009.
BRUSSELS (Reuters) – The European Commission’s new president, Jean-Claude Juncker, comfortably survived a no-confidence vote on Thursday brought over news that Luxembourg had lured multinational businesses with super low tax rates during his period as prime minister.
The censure motion in the European Parliament in Strasbourg, France, was resoundingly defeated by 461 votes to 101.
BRUSSELS (Reuters) – European Union lawmakers overwhelmingly backed a motion on Thursday urging antitrust regulators to get tough on Google and other Internet search engines and consider breaking them up.
The resolution in the European Parliament (EP), the strongest public signal of Europe’s concern with the growing power of U.S. tech giants, was passed with 384 votes for versus 174 against.
BRUSSELS/LONDON, Nov 26 (Reuters) – Zinc producer Nyrstar SA
has ousted its chief executive and is replacing him
temporarily with its finance chief, a surprise change only weeks
after commodities trader Trafigura bought a large
stake in the company.
Nyrstar said Roland Junck, 59, had left to pursue other
interests after nearly six years in the post and Chief Financial
Officer Heinz Eigner had been appointed acting CEO while the
board seeks a permanent replacement.
BRUSSELS (Reuters) – European campaigners against an EU-U.S. accord have held up progress towards the world’s biggest free trade deal by deluging an online public consultation that EU officials had hoped would help them unblock a key issue.
Of almost 150,000 submissions to the public forum on how to protect businesses from unfair government interference, over 95 percent were from supporters of a small group of organisations hostile to a deal with Washington and who submitted identical or very similar responses, two EU officials have told Reuters.
BRUSSELS, Nov 26 (Reuters) – European campaigners against an
EU-U.S. accord have held up progress towards the world’s biggest
free trade deal by deluging an online public consultation that
EU officials had hoped would help them unblock a key issue.
Of almost 150,000 submissions to the public forum on how to
protect businesses from unfair government interference, over 95
percent were from supporters of a small group of organisations
hostile to a deal with Washington and who submitted identical or
very similar responses, two EU officials have told Reuters.
BRUSSELS (Reuters) – Belgian biotech company Ablynx believes its sales estimate for its drug for the rare blood disease TTP is conservative, after tests showed it had potential to treat more than just acute cases.
Ablynx recently raised its estimate for peak annual sales for the TTP candidate drug caplacizumab to 300-400 million euros ($373-497 million), from up to 250 million euros previously.